baber/WOPTO huggingface dataset:
Patent NZ-522736-A (NZ)
Title: Flexible joint
Inventor: BYSTROM JOHAN
IPC: F16L27/08
Filed: 2001-06-19
Abstract: The invention relates to a flexible joint intended to connect two parts with each other, the connected parts might be rigid, of hose type or a combination thereof and are for instance of the pipe type used in vacuum cleaners, in which case the joint is intended to be placed between the rigid pipe member that is connected to the nozzle of the vacuum cleaner and the hose that is connected of the vacuum cleaner machine itself, which joint comprises: a plurality of ball joints (3-6), which co-operate with each other and which make possible for the joint to bend from a position, where the two parts and the joints that connects the two parts are essentially horizontally directed, two positions, where one of the parts (1) form an angle ( alpha ) with the other part; and a member (16) which is displaceable inside the ball joints (3-6) to different positions in relation to these, said member being able to go into engagement with and lock one or several of the ball joints (3-6). According to the invention, a flexible envelop (18) is applied on the outside of the ball joints (3-6), which envelop (18) is arranged to cover the areas between the ball joints (3-6).
Patent NZ-524685-A (NZ)
Title: Short-length reduced-pressure backflow preventor
Inventor: DUNMIRE CHARLES W
IPC: E03B7/07
Filed: 2001-09-07
Abstract: A double check valve reduced pressure backflow preventor assembly is configured to have a relatively small length, volume and/or weight. The assembly defines parallel, preferably coaxial, inlet (112) and outlet (128) directions. In one aspect, axis (312) of first and the axis (314) of second check valves are at an angle, preferably of 90 degrees, to the in-line axis (110). In one aspect, a relief valve (134) is positioned spaced from the in-line axis (110). First (718a) and second stop valves (718b) are enclosed in the same integral, unitary housing (142) which encloses the check valves and, preferably, some or all of the relief valve (134). The shutoff valves (718a, 718b) are preferably positioned along the in-line axis (110).
Patent NZ-526472-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: BEBBINGTON DAVID
IPC: A61K31/55
Filed: 2001-12-19
Abstract: Described are novel pyrazole compounds of formula I' wherein Q' is -O-, -C(R6')2, 1,2-cyclopropanediyl, 1,2-cyclobutanediyl, or 1,3-cyclopropanediyl, and R1 is T-(Ring D), wherein Ring D is 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rx and Ry are independently selected from T-R3 or L-Z-R3, or Rx and Ry are taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-7 membered ring having 0-3 heteroatoms; and R2 and R2' are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
Patent NZ-531396-A (NZ)
Title: A vehicle attachment for folding a ground cover
Inventor: KING MATTHEW
IPC: B65H75/40
Filed: 2004-02-26
Abstract: Disclose is a ground cover removal attachment for a vehicle for moving a ground cover of sheet material laid out on the ground, the attachment comprising and arm having a connection at one end of the arm for mounting the arm to a vehicle so that the arm extends outwardly of one side of the vehicle, and having a shaped outer end comprising one part which extends laterally outwardly so that when the arm is so mounted to a vehicle the one part can move beneath a side margin of the ground cover on one side of the ground cover as the vehicle moves forwardly alongside the ground cover, and another part adapted to contact a side edge of the ground cover as the vehicle moves alongside the ground cover.
Patent NZ-531599-A (NZ)
Title: Pharmaceutical compositions that dissolve rapidly comprising a macrolide solid, a disintegrant and 1 to 5% of a colloidal silicon dioxide by weight
Inventor: HAEBERLIN BARBARA
IPC: A61P25/28
Filed: 2002-09-27
Abstract: A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight is described. Also described are particularly rapidly-dispersing compositions comprising a macrolide solid dispersion, which can be provided by using colloidal silicon dioxide to promote disintegration. Colloidal silicon dioxide is known primarily as a lubricant or flow-regulating agent in pharmaceutical compositions. Here it is used for such purposes, silicon dioxide typically comprises around 0.5% by weight of the composition. The inclusion of 1 to 5% by weight of colloidal silicon dioxide has been found to be particularly effective in promoting disintegration of a macrolide solid dispersion in an aqueous solution, when combined with another disintegrant.
Patent NZ-531638-A (NZ)
Title: A method of displaying images transmitted over a slow data link
Inventor: BURSILL DONALD WILLIAM
IPC: H04N19/895
Filed: 2002-09-11
Abstract: A method of presenting images corresponding to image data transmitted over a data link, comprises: receiving first image data corresponding to a first image; displaying the first image; receiving second image data corresponding to a second image; displaying the second image; and if third image data corresponding to a third image has been received before the expiry of a set period of time after the display of the second image, displaying the third image; or if the third image data has not been received before the expiry of the set period of time after the display of the second image, displaying the first image again.
Patent NZ-531896-A (NZ)
Title: Extruder die assembly for an extruder producing an extruded food piece containing a filling
Inventor: HUNTER THOMAS B
Filed: 2001-09-12
Abstract: A die and cutter assembly 1 for an extruder for producing an extruded food piece containing a filling. The extruder includes two pressure vessels, the first containing a mash of the food under pressure and the second containing the filling under pressure, pressure exerting means for maintaining pressure in the pressure vessels. The die and cutter assembly is in fluid connection with the two pressure vessels through manifolds, and includes an elongated annular extrusion member 9. A filling tube 20 extends into the elongated annular extrusion member 9. A tube extension 24 is formed on the filling tube 20 substantially at a right angle thereto and located within the extension 22 of the elongated annular extrusion member 9. In addition, an extrusion die 13 is formed on the extension 22 of the elongated annular extrusion member 9 and a cutter member 14 having an opened driveable end 15, an elongated cutter wall 16, and an opened cutter end 17 with a cutting surface 18 for cutting extrudate to a desired length as the extrudate exits the die 13. The cutter member is disposed at least partially over and reciprocally slideable on the extrusion wall 10 and is operably connectable at the driveable end 15 to a drive device for reciprocatably sliding the cutter member 14 over and away from the extrusion die 13.
Patent NZ-532376-A (NZ)
Title: Wire tie off tool
Inventor: NEWDICK WAYNE
IPC: B21F15/04
Filed: 2004-04-15
Abstract: Disclosed herein is a wire tie off tool in the form of a component or an assembly to provide a first-order or second-order lever system using the component or assembly on a wire as the fulcrum about which the wire tie off as the load is to be wound, the component or assembly defining when engaged to such a wire as a fulcrum defining a lever having (a) means to engage the wire tie off region as the lever load that does not require wire threading through an aperture, and (b) means to engage or engaging the wire to locate the wire as the fulcrum ("engagement means") as the engagement means migrates about the wire. Alternatively, the wire tie off tool is described as comprising or including interrelated components adapted to sandwich or clasp (hereafter "sandwich") a wire ("the wire") about which a tie off wire is to be wound to define a lever adapted to define one or more predetermined lever fulcrum at the wire in a sandwiching mode, and a wire engagement feature spaced from any such lever fulcrum adapted, upon rotation of the tool on such wire, thereby to migrate the fulcrum about the wire, of carrying a wire tie off region about the wire, the arrangement being such that the interrelated components can be fulcrum associated with a said wire and the tie off wire region can be associated with said wire engagement feature whereby, with rotation of the tool on such wire, the wire tie off region can be wound about the wire.
Patent NZ-534862-A (NZ)
Title: Apparatus for preparing hot liquid beverages using a peristaltic pump for dispensing the beverage stored in an aseptic bag
Inventor: FRANCOIS JEAN-JACQUES
IPC: A47J31/41
Filed: 2003-02-03
Abstract: The invention concerns an apparatus for preparing hot beverages, in particular soups, characterized in that it comprises a frame (1) wherein are arranged means (2) for heating water from a drinking water distribution system or from a container and for transforming it into pressurized steam and means for directing said steam towards a chamber (3) which is traversed by a discharge duct (4) wherein flows the liquid beverage to be prepared, said beverage being transported to said duct (4) up to a container (5) by means (6) sequentially dispensing the beverage stored in a sanitary casing (61) arranged in a removably mounted receptacle (7) housed in the frame (1).
Patent NZ-536781-A (NZ)
Title: Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
Inventor: FLOERSHEIMER ANDREAS
IPC: A61P29/00
Filed: 2003-05-28
Abstract: A diaryl urea derivative of formula (IÆ), wherein the variables are as defined in the specification, and a process for the preparation of these diaryl urea derivatives is disclosed. These diaryl urea derivatives are suitable for the treatment of leukaemia.
Patent NZ-540328-A (NZ)
Title: Fused heterocyclic compounds
Inventor: CHEN XI
IPC: C07D471/04
Filed: 2003-11-06
Abstract: Disclosed is a compound of formula I, wherein Ar represents a single or fused aryl or heteroaryl ring, Q is -N(R)- or -N(R)-(C1-C3)alkylene-, and the remaining substituents are as defined in the specification. The compounds are useful in the treatment of diseases which are mediated by the melanin concentrating hormone receptor, such as obesity, eating disorders, anxiety disorders and mood disorders.
Patent NZ-542678-A (NZ)
Title: Advertising display panel with diffusion of scents
Inventor: BENALIKHOUDJA KARIM
IPC: G09F15/00
Filed: 2004-03-29
Abstract: Disclosed is an advertising panel (1) which is designed to display an advertising message and to diffuse a scent which is associated with the contents of the visually-displayed message. The inventive panel comprises a parallelepiped volume containing: an assembly which is used to display an advertising message that is disposed opposite a display window (7), and at least one scent diffuser (10) which is connected to a scent-diffusing element (11) which is in turn installed opposite an opening (1a) in the panel, such as to diffuse a scented flow to the exterior. The aforementioned diffusing element (11) is connected to the head (13) of the scent diffuser (10), thereby ensuring that a carrier gas is mixed with the scented fluid contained in the receptacle (12). According to the disclosure, the scented flow obtained at the outlet of the head is pulsed towards the diffusing element (11) and, subsequently, to the exterior of the panel.
Patent NZ-548461-A (NZ)
Title: Smart meter parking system
Inventor: GROFT ERIC
IPC: H04W84/10
Filed: 2006-07-12
Abstract: A wireless electronic parking meter control system is disclosed. The wireless electronic parking meter control system comprises: (a) a vehicle detection system for determining the presence or absence of a vehicle in a plurality of vehicle parking spaces; (b) a number of electronic parking meters, each associated with a given vehicle parking space; (c) a number of intelligent communications modules (ICMs), at least one of which is interconnected with the vehicle detection system, and the number of electronic parking meters; (d) the at least one ICM is wirelessly interconnected with the remaining number of ICMs; (e) an intelligent network bridge is wirelessly interconnected to the remaining number of ICMs, and connected to the internet; (f) a license plate recognition system which includes a mobile camera unit, desktop computer, and a global positioning satellite terminal, which is connected to the Internet; and (g) a server interconnected to the internet via a router/ firewall circuit for isolating the server from the internet.
Patent NZ-550757-A (NZ)
Title: Imidazole derivatives used as tafia inhibitors
Inventor: KALLUS CHRISTOPHER
IPC: A61K31/41
Filed: 2005-04-07
Abstract: Disclosed are amino-pyridinyl imidazole derivatives as represented by the general formula (la), where U is hydrogen, X is -CH2-A2, A2 is optionally substituted aminopyridyl, Y is optionally substituted cycloalkyl, Z is hydrogen, alkyl, alkyl-OH, alkyl-cycloalkyl or alkyl-O-C(O)-O-cycloalkyl, and wherein the other substituents are as defined herein. Also disclosed is the use of a compound as defined above for producing a medicament for the prophylaxis and therapy of all disorders associated with thromboses, embolisms, hypercoagulability or fibrotic changes (including disorders such as myocardial infarction, angina pectoris and other types of acute coronary syndrome, stroke, peripheral vascular disorders, deep vein thrombosis, pulmonary embolism, embolic or thrombotic events caused by cardiac arrhythmias, cardiovascular events such as restenosis following revascularization, angioplasty, stent implantations, bypass operations and similar procedures, reduction of the risk of thrombosis following surgical procedures, disseminated intravascular coagulation, sepsis and other intravascular events which are associated with an inflammation, atherosclerosis, diabetes and metabolic syndrome and its squelae, tumor growth and tumor metastasis, impairments of the hemostatic system such as fibrin deposits, fibrotic changes of the lung such as chronic obstructive lung disease, adult respiratory distress syndrome or fibrin deposits in the eye after eye operations or prevention and/or treatment of scar formation).
Patent NZ-552544-A (NZ)
Title: Method and composition for high level disinfection employing quaternary ammonium compounds
Inventor: KRITZLER STEVEN
IPC: A61L2/04
Filed: 2005-07-07
Abstract: Provided is a method of high level disinfection (as herein defined) of a surface by reducing Mycobacterium terrae on the surface including the step of treating the surface with a composition including a quaternary ammonium compound wherein the concentration of said quaternary ammonium compound exceeds 1 % w/w and the temperature of treatment is in the range of from 30°C to 80°C, whereby to achieve log 6 reduction in Mycobacterium terrae on the surface in less than 10 minutes.
Patent NZ-554237-A (NZ)
Title: Vibration absorber, and vibration control structure using the same
Inventor: MOCHIMARU MASAMI
IPC: F16F9/30
Filed: 2003-02-07
Abstract: A damper (101) includes a hollow outer elongated body (21) formed of a cylindrical member, a hollow inner elongated body (102) similarly formed of a cylindrical member, and an intermediate hollow elongated body (22) also formed of a cylindrical member, and a viscous body (26) disposed in the respective gaps between an inner surface of the outer elongated body and an outer surface of the intermediate elongated body and between an inner surface of the intermediate elongated body and an outer surface of the inner elongated body in such a manner as to be in contact with the inner surfaces and the outer surfaces. A first attaching means is provided on axial end portions of the outer elongated body and the inner elongated body, and a second attaching means is provided on an end portion of the intermediate elongated body, the respective attaching means including respective plate members (31, 32).
Patent NZ-555077-A (NZ)
Title: Parenteral combination therpy for infective conditions with drug resistant bacterium
Inventor: CHAUDHARY MANU
IPC: A61K31/00
Filed: 2006-02-08
Abstract: The disclosure relates to a synergistic pharmaceutical composition, that is parenterally administrable, comprising an anti bacterially effective amount of at least two anti bacterial agents which are chemically incompatible wherein: a) a first anti bacterial agent consisting of Vancomycin, or a pharmaceutical acceptable salt thereof, and b) a second anti bacterial agent consisting of Ceftriaxone, or a pharmaceutically acceptable salt thereof, c) the said first and said second antibacterial agents are present in predetermined weight ratio of about 1:4 to about 4: 1, preferably from about 1:3 to about 3:1 and more preferably from about 1:2 to about 2:1 along with d) a chemical vector, to mediate the compatibility of the said first antibacterial agent and the said second antibacterial agent to render stability to the composition, which is L arginine in the range of about 35% to about 75% of the combined weight of said first and said second antibacterial agent, e) the composition thus formed has lower dose of therapeutic agents which is safe due to decrease in toxicity, increased efficacy and minimizes the risk of systemic effects f) said pharmaceutical composition being supplied as a dry powder premix ready for injection after reconstitution in a suitable vehicle, g) for the use as an antimicrobial fixed dose combination therapy for a mammal including the human being with the provision that said combination therapy does not encompass administration of two or more therapeutic agents as part of separate mono therapy regimens that results in sequential or simultaneous treatment. Also disclosed is a process for preparing a suitable solvent vehicle containing said pharmaceutical composition and the use of said pharmaceutical composition in the manufacture of a medicament for the treatment of disorders caused by gram positive or gram negative organisms.
Patent NZ-574264-A (NZ)
Title: Production of a refinery feedstock from soaps produced during a chemical pulping process
Inventor: LOGAN MARK JAMES
IPC: C10L1/19
Filed: 2006-11-17
Abstract: Disclosed is a process for preparing a refinery feedstock from black liquor soap obtained from a chemical pulp mill comprising: (a) separating black liquor soap from pulping liquor produced in a chemical pulp mill and placing the black liquor soap in a vessel; (b) mixing the black liquor soap in the vessel with a quantity of alcohol (such as methanol, ethanol or isopropanol) sufficient to esterify resin and fatty acids in the black liquor soap; and(c) mixing the product resulting from step (b) in the vessel with a quantity of acid (such as sulfuric acid, formic acid or hydrochloric acid for reducing the pH of the mixture to about 2) sufficient to remove sodium ion from the black liquor soap;(d) separating solids from the product of step (c); and(e) refining the product of step (d) to produce a refinery feed stock, wherein the solids from the product of step (c) are filtered and the product of step (d) is distilled to reclaim methanol or obtain biodiesel or sterols and related alcohols.
Patent NZ-586853-A (NZ)
Title: Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
Inventor: ALEKSOV JULIAN
IPC: A61K9/14
Filed: 2008-12-18
Abstract: Disclosed is a drug delivery system for administration of a pharmaceutically active substance that is a cationic amphiphile by itself and has a solubility per se in water of at least 4 mg/ml, wherein the drug delivery system comprises nanoparticles smaller than about 50 nm having a solubility in water below 0.1 mg/ml, said nanoparticles being formed by said substance in association with a sodium salt of the methyl ester of N-all-trans-retinoyl cysteic acid, a sodium salt of methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof. Also disclosed is a composition comprising the delivery system and the method of preparing a drug delivery system or a composition comprising the delivery system and the use of the drug delivery system or a composition comprising the delivery system in the manufacture of a medicament. Further disclosed is the use of a sodium salt of the methyl ester of N-all-trans-retinoyl cysteic acid, a sodium salt of the methyl ester of N-13-cis-retinoyl cysteic acid, or a combination thereof in the preparation of a drug delivery system and a method for enhancing drug efficiency or bioavailability.
Patent NZ-592927-A (NZ)
Title: PHOSPHODIESTERASE TYPE III (PDE III) INHIBITORS OR CA2+-SENSITIZING AGENTS such as pimobendan FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
Inventor: DAEMMGEN JUERGEN
IPC: A61K31/10
Filed: 2009-11-23
Abstract: 592927 The present disclosure relates to a phosphodiesterase type III (PDE III) inhibitor and/or Ca2+- sensitizing agent or a pharmaceutically acceptable derivative thereof, specifically pimobendan for the treatment of a patient suffering from hypertrophic cardiomyopathy (HCM). According to another aspect the present disclosure relates to the use of a PDE III inhibitor and/or Ca2+-sensitizing agent for the preparation of a medicament for the treatment of a cat suffering from HCM.
Patent NZ-593162-A (NZ)
Title: Database fragment cloning and management
Inventor: GERBER ROBERT H
IPC: G06F17/30
Filed: 2006-07-20
Abstract: A device-executable method for monitoring and updating cloned fragments comprises the steps of monitoring cloned fragments associated with a database object with the cloned fragment including primary and secondary cloned fragments; determining that at least one of the cloned fragments has become unavailable; incrementing an update identifier associated with the database object; transactionally persisting the update identifier; identifying a DML statement associated with the database object with the DML statement including an update to the database object; associating the persisted update identifier with the DML statement; implementing the update on the primary cloned fragments that are affected by the DML statement; storing the update identifier associated with the DML statement in each row in the primary cloned fragments that is affected by the update; propagating the update and the update identifier to the secondary cloned fragments associated with the affected primary cloned fragments and storing the update identifier on the secondary cloned fragments.
Patent NZ-595889-A (NZ)
Title: Bottle neck with internal embossments and method manufacture
Inventor: LONSWAY MICHAEL J
IPC: B29C49/04
Filed: 2009-09-17
Abstract: 595889 A longneck glass or metal bottle of one-piece integrally formed construction has a body (22) with a closed base (24) and a shoulder (26) at an end of the body remote from the base, and a neck (28) extending from the shoulder along an axis and terminating in a neck finish (32) for attachment of a closure The bottle neck includes at least one internal embossment for affecting flow of liquid from the body through the neck. In exemplary embodiments of the disclosure, the at least one internal embossment includes at least one internal spiral (40). Alternatively shaped embossments are disclosed.